Skip to content

Search

Search managers or tickers

Abrams Capital

Q3 2023 13F · by David Abrams, founder

As of
Sep 30, 2023
Filed
Nov 13, 2023
US stock
$3.0B · prev $3.5B
Positions
15 · prev 17
Options notional
$0
Documents
1· no amendments

Picture100.0% US stock

Full picture · of what this 13F reports is US stock

  • US stock listed on a US exchange 100.0%
  • Foreign stock not listed in the US 0.0%
  • Notes debt, at principal 0.0%
  • Puts at notional value 0.0%
  • Calls at notional value 0.0%

Moves4 since the prior filing

The book

Very concentrated · behaves like 8 equal-sized positions

  1. Very concentrated
  2. Concentrated
  3. Focused
  4. Diversified

Low turnover · 1.6% a year, more than 30 years per position

  1. Low
  2. Moderate
  3. High

Top 5 positions67% of US stock

  1. LAD Lithia Motors, Inc. added+2.77 pp added+2.7723.3%
  2. ABG Asbury Automotive Group, Inc. held held16.0%
  3. GOOGL Alphabet Inc. Class A held held10.0%
  4. META Meta Platforms, Inc. Class A trimmed−0.18 pp trimmed−0.189.2%
  5. ET Energy Transfer LP held held8.3%

Positions15 in this filing · 2 exited

LADLithia Motors, Inc.23.33%2,391,188$706Madded+2%+2.77 pp22 q
ABGAsbury Automotive Group, Inc.16.03%2,108,540$485Mheld—25 q
GOOGLAlphabet Inc. Class A10.04%2,322,340$304Mheld—22 q
METAMeta Platforms, Inc. Class A9.21%928,474$279Mtrimmed−18%−0.18 pp20 q
ETEnergy Transfer LP8.27%17,834,322$250Mheld—15 q
CPNGCoupang, Inc.7.31%13,017,964$221Mheld—9 q
UHAL.BU-Haul Holding Company6.34%3,663,243$192Mheld—4 q
WTWWillis Towers Watson Public Limited Company5.57%806,836$169Mheld—28 q
SGISomnigroup International Inc.5.16%3,600,000$156Mheld—9 q
CWHCamping World Holdings, Inc.3.45%5,108,808$104Mheld—21 q
TEVATeva Pharmaceutical Industries Limited2.68%7,966,433$81Mheld—25 q
UTE0USA Technologies, Inc.1.48%7,180,000$45Mheld—11 q
UHALU-Haul Holding Company0.73%407,027$22Mheld—28 q
USCBUSCB Financial Holdings, Inc. Class A0.23%649,085$7Mheld—8 q
NUVBNuvation Bio Inc.0.17%3,811,513$5Mheld—11 q
TDGTransDigm Group Incorporated—−312,747—exited−8.04 pp—
HZNPHorizon Therapeutics PLC—−890,993—exited−2.64 pp—

Source

Form
13F-HR
Reading
0 defects · 0 unresolved
Options
none in this filing
Notes
none in this filing
SEC cross-check
SEC data set not published yet